NO20013905L - Lantibiotika - Google Patents

Lantibiotika

Info

Publication number
NO20013905L
NO20013905L NO20013905A NO20013905A NO20013905L NO 20013905 L NO20013905 L NO 20013905L NO 20013905 A NO20013905 A NO 20013905A NO 20013905 A NO20013905 A NO 20013905A NO 20013905 L NO20013905 L NO 20013905L
Authority
NO
Norway
Prior art keywords
salivaricin
lantibiotics
applications
bacteriocidal
pyogenes
Prior art date
Application number
NO20013905A
Other languages
English (en)
Other versions
NO326899B1 (no
NO20013905D0 (no
Inventor
John Robert Tagg
Karen Patricia Dierksen
Mathew Upton
Original Assignee
Blis Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blis Technologies Ltd filed Critical Blis Technologies Ltd
Publication of NO20013905D0 publication Critical patent/NO20013905D0/no
Publication of NO20013905L publication Critical patent/NO20013905L/no
Publication of NO326899B1 publication Critical patent/NO326899B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Peptides Or Proteins (AREA)
  • Confectionery (AREA)
  • Medicinal Preparation (AREA)
  • Dairy Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20013905A 1999-10-12 2001-08-10 Antibakterielt protein samt anvendelser derav, terapeutisk formulering, polynukleotid og isolert organisme. NO326899B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ50026199 1999-10-12
PCT/NZ2000/000197 WO2001027143A1 (en) 1999-10-12 2000-10-12 Lantibiotic

Publications (3)

Publication Number Publication Date
NO20013905D0 NO20013905D0 (no) 2001-08-10
NO20013905L true NO20013905L (no) 2001-10-10
NO326899B1 NO326899B1 (no) 2009-03-16

Family

ID=19927569

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013905A NO326899B1 (no) 1999-10-12 2001-08-10 Antibakterielt protein samt anvendelser derav, terapeutisk formulering, polynukleotid og isolert organisme.

Country Status (15)

Country Link
US (2) US6773912B1 (no)
EP (1) EP1169340B1 (no)
JP (1) JP3673497B2 (no)
AT (1) ATE362481T1 (no)
AU (1) AU772224B2 (no)
BR (1) BR0014740A (no)
CA (1) CA2363713C (no)
DE (1) DE60034879T8 (no)
DK (1) DK1169340T3 (no)
ES (1) ES2286038T3 (no)
HK (1) HK1039622B (no)
NO (1) NO326899B1 (no)
PL (1) PL206441B1 (no)
RU (1) RU2279481C2 (no)
WO (1) WO2001027143A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070919A1 (en) * 2002-02-22 2003-08-28 Blis Technologies Limited Antimicrobial composition
US6861236B2 (en) 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
WO2004072272A1 (en) * 2003-02-14 2004-08-26 Blis Technologies Limited Bacterial compositions
DK1653982T3 (en) * 2003-07-18 2019-01-14 Blis Tech Limited TREATMENT OF HALITOSIS
EP1730180A4 (en) * 2004-02-24 2008-06-18 Commw Scient Ind Res Org ANTIFUNGAL PEPTIDES
US8415289B2 (en) * 2005-12-13 2013-04-09 The Trustees Of The University Of Pennsylvania Bacterial-derived BLIS for treatment of acne
FR2905268B1 (fr) * 2006-09-01 2009-01-23 Unither Dev Soc Par Actions Si Substitut salivaire
KR101432336B1 (ko) * 2006-12-19 2014-08-20 바스프 에스이 뮤탄스 연쇄상구균에 의해 유발된 우식증의 예방 및/또는 치료를 위한 용도 및 방법
GB0921995D0 (en) * 2009-12-17 2010-02-03 Univ Manchester Antimicrobial peptides
HUE030227T2 (en) * 2010-04-07 2017-05-29 Dmg Italia Srl Use of Streptococcus salivarius to treat chronic infections of the respiratory tract
DE102012203547A1 (de) * 2012-03-07 2013-09-12 Robert Bosch Gesellschaft Für Medizinische Forschung Mbh Antimikrobielle Peptide
CA2783414A1 (en) * 2012-07-22 2014-01-22 Integral Medical Inc. Probiotic composition
CN104398537A (zh) * 2014-11-17 2015-03-11 南京灿辰微生物科技有限公司 一种口腔益生菌组合物
CN111227035A (zh) * 2018-11-28 2020-06-05 内蒙古伊利实业集团股份有限公司 一种含益生菌组合物的发酵乳及其制备方法
CN112391305B (zh) * 2019-08-15 2023-01-13 上海交通大学 唾液链球菌f286及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925160A (en) * 1974-09-26 1975-12-09 Univ Creighton Method of producing an antibiotic
JPS615022A (ja) * 1984-06-19 1986-01-10 Advance Res & Dev Co Ltd 腸内細菌叢改善剤
SE463349B (sv) 1989-02-15 1990-11-12 Grahn Eva E Farmaceutiskt preparat foer profylax mot och/eller behandling av beta-streptokockinducerad tonsillit
JPH054927A (ja) * 1991-06-28 1993-01-14 Aizo Matsushiro 乳酸菌含有組成物及びその製造方法
US5872001A (en) 1994-04-20 1999-02-16 Uab Research Foundation Lanthionine antibiotic compositions and methods

Also Published As

Publication number Publication date
DK1169340T3 (da) 2007-09-24
DE60034879T2 (de) 2008-02-07
RU2279481C2 (ru) 2006-07-10
US6773912B1 (en) 2004-08-10
ATE362481T1 (de) 2007-06-15
ES2286038T3 (es) 2007-12-01
EP1169340B1 (en) 2007-05-16
HK1039622B (zh) 2007-10-18
AU7973700A (en) 2001-04-23
CA2363713C (en) 2007-11-06
WO2001027143A1 (en) 2001-04-19
US20040232205A1 (en) 2004-11-25
DE60034879D1 (en) 2007-06-28
CA2363713A1 (en) 2001-04-19
EP1169340A4 (en) 2005-06-08
JP2003516123A (ja) 2003-05-13
BR0014740A (pt) 2002-06-18
PL206441B1 (pl) 2010-08-31
HK1039622A1 (en) 2002-05-03
JP3673497B2 (ja) 2005-07-20
PL364771A1 (en) 2004-12-13
NO326899B1 (no) 2009-03-16
NO20013905D0 (no) 2001-08-10
AU772224B2 (en) 2004-04-22
EP1169340A1 (en) 2002-01-09
DE60034879T8 (de) 2008-07-03

Similar Documents

Publication Publication Date Title
ATE362481T1 (de) Lantibiotikum
CY1110914T1 (el) Δικυκλο-πυραζολες δραστικες ως αναστολεις kinασων, διεργασια για την παρασκευη τους και φαρμακευτικες συνθεσεις που τις περιλαμβανουν
SE0102315D0 (sv) Compounds
YU91603A (sh) Kristalni oblici azitromicina
DE60113851D1 (de) Bakteriophage mit breitem wirtspektrum
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
CY1105343T1 (el) Σταφυλοκοκκικη πρωτεϊνη αναστολης του χημειοτακτισμου (chips) και η χρηση αυτης
MA28613B1 (fr) Macrocycles d'amide antibacteriens
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
DK1228097T3 (da) Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
WO2000058475A3 (en) Streptococcus pneumoniae antigens
ATE259654T1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
UY26763A1 (es) Inmunización del ganado lacteo con proteína gapc quimérica contra infección por estreptococo.
ATE301194T1 (de) Beta-defensine
DK1343896T3 (da) Lille syreoplöseligt sporeprotein og anvendelser deraf
DE60235132D1 (de) Sojaprodukte enthaltende Zusammensetzungen
PT1276495E (pt) Utilizacao de tensioactivo pulmonar recombinante para o tratamento precoce de doencas pulmonares agudas
WO2001096381A3 (en) IMMUNIZATION OF DAIRY CATTLE WITH GapC PROTEIN AGAINST STREPTOCOCCUS INFECTION
BR0309569A (pt) Vacinas em combinação que incluem polipeptìdeos imunogênicos de fator camp e gapc
ATE452191T1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
PT1232173E (pt) Derivados do acido fusidico
ATE313628T1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
TR200003301T2 (tr) Morfolino eterler
BR0007491A (pt) Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções
EP1734050A3 (en) Immunization of dairy cattle with GapC protein against streptococcus infection

Legal Events

Date Code Title Description
MK1K Patent expired